Beth Seidenberg
Westlake Village BioPartners Managing Director
location
San Francisco, California
investment range
$100k - $25.0m
sweet spot
$10.0m
Beth Seidenberg's Past Investments (33)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Tmunity Therapeutics | Series A | $35M | Apr 2018 | |
| Expansion Therapeutics | Series A | $55.3M (Lead) | Jan 2018 | |
| ARMO BioSciences | Series C | $67M | Aug 2017 | |
| Progyny | Series B | $10M | May 2017 | |
| Progyny | Series B | $14.7M | Jun 2016 | |
| TESARO | Post-IPO Equity | $155M (Lead) | Mar 2016 | |
| ARMO BioSciences | Series C | $50M | Feb 2016 | |
| Flexus Biosciences | Venture Round | $15.2M (Lead) | Mar 2015 | |
| Breathe Technologies | Venture Round | $810K | Jan 2015 | |
| 3-V Biosciences | Series D | $28.5M (Lead) | Dec 2014 |
Beth Seidenberg's Media
No media found for Beth Seidenberg.